BOSTON--(BUSINESS WIRE)--DeepCure, a therapeutics company using AI to discover novel drugs for inflammation and immune diseases, will present new in vivo data demonstrating its selective BRD4 (BD2) ...
Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. This disease prompts the ...
The device is covered by Medicare but not by all commercial insurance, particularly Blue Cross Blue Shield.
Inconsistent information on rheumatoid arthritis outcomes affects patient decision-making, highlighting the need for standardized health outcome descriptors (HODs). Important outcomes like pain, joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results